logo
Government plans to wind down National Polio Surveillance Network centres in India

Government plans to wind down National Polio Surveillance Network centres in India

The Hindu2 days ago

The government has proposed to wind down, in phases, the World Health Organization (WHO)-established National Polio Surveillance Network (NPSN), currently a countrywide network of over 200 units. Experts in the field have commented that the move would be premature and ill-advised at this stage, with India's neighbouring countries still harbouring cases of polio.
Staff at the NPSN centres have received a communication from the WHO's representative in India, Roderico H. Ofrin, advising them of an upcoming transition initiated by the government. The transition involves a gradual drawdown of the NPSN units each year — from approximately 280 units in 2024-25 down to 190 in 2025-26, and further to 140 in 2026-27. This is also linked with a corresponding reduction in financial support from the government, according to the communique.
The process of transition will begin in June.
'We are not disbanding teams overnight or winding down the network haphazardly; rather, specific units will phase out at set intervals as government systems ramp up and absorb these functions,' Dr. Ofrin said. This will help us ensure that, at any given time, critical surveillance activities continue with minimal or no gaps, he said.
While he assured the staff of the NPSN that this would help retain critical surveillance activities, at some point, polio surveillance would be subsumed within the Integrated Diseases Surveillance Programme.
But the proposed winding down of a key unit, at a time when global resurgence of polio has been reported, has not gone down well, with either staffers or public health experts.
India was declared polio-free in 2014, after three years of no case caused by wild polio virus transmission. The gains came after a full-frontal attack launched on polio, through years of coordinated work and oral polio immunisation campaigns, with a number of organisations collaborating.
Jacob John, prominent virologist and vaccine expert, who has been actively involved in polio eradication efforts, including as a member on the National Technical Advisory Group on Immunisation, said he was 'horrified' by the move. 'The world has lots of polio still. It is way too early to upset our current 'steady state',' he added.
He pointed out that Afghanistan and Pakistan continued to have polio cases, and that it is too close for comfort, also pointing to the danger of vaccine-derived polio virus. 'For every type 1 wild virus polio in Pakistan, there are about 10-12 circulating vaccine-derived poliovirus polio cases, mostly type 2, globally. After April 2016, we have not immunised children against type 2. In case vaccine derived polio virus is imported into India, widespread transmission and polio cases by the dozen are expected,' Dr. John said.
A long-time campaigner for injectable polio vaccines (IPVs), Dr. John suggests that India should first replace oral polio vaccine (OPV) with IPV. After one year, all OPV can be withdrawn. Then, one year later, we can look at dismounting the watch. 'If surveillance is diluted now, we become sitting ducks for the resurgence of polio due to circulating VDPV, type 2 most likely, and type 1 less likely,' Dr. John said.
Dr. Ofrin's letter also touches upon job security for existing staff, but the polio surveillance medical officers in the country under the Special Services Agreement, said it's not at all reassuring. 'Each centre has at least four employees. Imagine the number of people who won't have a job,' one doctor said, speaking on condition of anonymity.
He also said that, since 2014, the NPSN had been functioning as a unit of the Central government, which expanded the role of the staff to conduct surveillance for measles and rubella, DPT (diphtheria, pertussis or whooping cough, and tetanus), child vaccination, and training the health workforce every time a new vaccine was introduced. He pointed out that there seemed to be no rationale in shutting down these particular centres. 'Vaccine-preventable diseases are a critical area; the country's progress should not be compromised at this stage,' he said.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AB-PMJAY, Jan Aushadhi Kendras boosting healthcare for middle class in last 11 years
AB-PMJAY, Jan Aushadhi Kendras boosting healthcare for middle class in last 11 years

Hans India

time2 hours ago

  • Hans India

AB-PMJAY, Jan Aushadhi Kendras boosting healthcare for middle class in last 11 years

New Delhi: Flagship scheme like the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and the Jan Aushadhi Kendras under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has significantly enhanced healthcare for middle class in the last 11 years, according to an official statement issued on Thursday. 'Healthcare in India has seen a quiet but far-reaching shift in the last eleven years. Through a blend of targeted public schemes and digital reach, the Government has made quality healthcare both affordable and accessible for millions, especially the middle class,' the statement said. With more than 41.02 crore Ayushman Cards created in 33 States and Union Territories, as of May 30, AB-PMJAY has emerged as one of the world's largest publicly funded health assurance schemes. The scheme has enabled 8.59 crore hospital admissions worth Rs 1,19,858 crore, ensuring access to secondary and tertiary care without pushing families into debt, the statement said. Further, with the number of Jan Aushadhi Kendras rising to 16,469, as of May 30, from just 80 in 2014, the PMBJP brought essential medicines within reach of the common citizen. These outlets offer medicines that cost 50 to 80 per cent less than branded options, with strict quality standards ensured through WHO-GMP certified suppliers. The scheme serves around 10 to 12 lakh people daily, and cumulative savings over the last eleven years are estimated to be more than Rs 38,000 crore, the statement said. The product range now includes 2,110 medicines, including for chronic conditions like diabetes or heart disease, and 315 surgical products, covering all major treatments, cutting down financial stress for millions of families, especially the middle class. 'From free hospitalisation for senior citizens to low-cost medicines available nationwide, people today have better control over their health expenses. The digital backbone supporting these schemes has made enrolment, access, and tracking easier than ever. This change has allowed the middle class to benefit from savings on medicines, timely treatment, and greater medical security without bureaucratic hassles,' the statement said. 'Over the past eleven years, the government has shown unwavering commitment to uplifting the middle class in meaningful ways. The policies and reforms introduced have not only eased everyday challenges but also strengthened financial security, housing, healthcare, and skill development,' it added.

All you need to know about: Alzheimer's disease
All you need to know about: Alzheimer's disease

The Hindu

time2 hours ago

  • The Hindu

All you need to know about: Alzheimer's disease

The deaths of actor Gene Hackman and his wife Betsy Arakawa made headlines some months ago after their bodies were found at their home in Santa Fe, United States. While Ms. Arakawa was found to have died of hantavirus pulmonary syndrome, a rare rodent-borne disease, Mr. Hackman's autopsy findings indicated severe heart disease as well as advanced stages of Alzheimer's disease. The actor was 95 at the time of his death. What is Alzheimer's disease and what do you need to know about it? Read on, to find out. What is Alzheimer's disease? Alzheimer's disease is the most common form of dementia, which is an umbrella term for several diseases that affect the brain, impairing memory, thinking, reasoning, affecting a person's ability to function well. Dementia is not a normal part of ageing. Alzheimer's disease, the World Health Organization (WHO) states, may contribute to 60–70% of dementia cases. Dementia is currently the seventh-leading cause of death and one of the major causes of disability and dependency among older people globally. India is expected to have about 7.6 million afflicted by 2030, as per the Dementia in India Report, 2020, majority of whom are likely to be diagnosed with Alzheimer's. Alzheimer's is a progressive, neurodegenerative disease, which means that over time, brain cells are damaged and die, leading the brain to shrink. What causes Alzheimer's disease? The exact causes that lead to Alzheimer's disease are still being studied and are not fully understood. Scientists believe the disease may be caused by the abnormal build-up of proteins in the brain. The brain is made up of billions of nerve cells or neurons that are connected in networks. When a protein called beta amyloid builds up and clumps together, it forms plaques that affect the communication between neurons. Another protein, the tau protein, becomes twisted into strands called tangles, which also affect the functioning of the cells, and damages them. When the cells become damaged and lose their connections with each other, they eventually die. The destruction and death of the brain nerve cells cause the symptoms of Alzheimer's. Genetics, environmental and environmental factors are believed to contribute to the cause. Who is at risk for Alzheimer's disease? Age, being 65 years or older, is one of the primary risk factors. Other risk factors include a family history of Alzheimer's, smoking, a traumatic head injury, untreated depression as well as lifestyle conditions associated with heart disease such as obesity, high blood pressure and high blood sugar. The WHO also lists drinking too much alcohol, being physically inactive and being socially isolated as risk factors for dementia. What are the signs and symptoms? One of the first and most common symptoms may be memory loss -- difficulty in remembering recent events or conversations and newly-learned information. This is not the occasional bout of forgetting that most of us may experience -- this form of memory loss is lasting. It may lead, over time, to patients having trouble finding the right words, asking questions over and over, putting familiar objects in unfamiliar places, getting lost in a previously well-known locations and forgetting faces and names. Other symptoms involve thinking and reasoning abilities as well as changes in speech, moods, personality and behaviour. These can include: confusion, difficulties in paying bills and managing finances, difficulties in day-to-day activities such as cooking or driving and poor judgement. Personality changes can include suspicion of others, mood swings, hallucinations, anxiety, depression, social withdrawal and anger or aggression. What is the prognosis? The rate of progression for Alzheimer's disease varies. In the later stages of the disease, a person may lose physical abilities, may need help with all activities, and may lost the ability to communicate. Some people may live several years after a diagnosis, while others may live for fewer years. The stage of the disease at the time of diagnosis and other factors of health may affect life expectancy. How is it treated? It is important to see a doctor if you are concerned about memory or other thinking skills or if you have these concerns about a family member. At present, there is no cure for Alzheimer's., however treatment can help manage symptoms and treat the progression of the disease. Early treatment is optimal to help preserve brain health. Medicines may be prescribed where necessary. This apart, medication may also be given for symptoms such as depression, hallucinations, agitation and mood changes. Opting for a healthy lifestyle including adequate exercise, well-balanced, nutritious meals, keeping up with hobbies and social activities, may all help. Creating a supportive and caring environment at home, one that is calm, structured, is also important to help improve well-being and the ability to function.

China's dirty game to end in this country! Plan to loot massive treasure exposed, citizens start protests after...., country is....
China's dirty game to end in this country! Plan to loot massive treasure exposed, citizens start protests after...., country is....

India.com

time2 hours ago

  • India.com

China's dirty game to end in this country! Plan to loot massive treasure exposed, citizens start protests after...., country is....

Anti-China protests in Myanmar [File: AP Photo] Bad news for China: In a significant development impacting the hegemony of China in India's neighborhood, the People's Republic of China has been accused of exploiting the resources of Myanmar and as a result, the local tribes of Myanmar are now protesting heavily against it. For those unversed, Myanmar went through a military coup in the year 2021 where the Chinese-backed Myanmar army overthrew the democratically elected government led by Aung San Suu Kyi. After the coup took place in Myanmar, the Chinese-backed Myanmar army began allowing large-scale mining projects, especially for toxic lead, damaging the environment, which is now leading to widespread protests. As per media reports, local tribal communities have risen in protest, blocking roads and halting Chinese operations, which is impacting the Belt and Road Initiative of China. 'Under no circumstances can we give this heritage received from our ancestors to China in exchange for money or wealth', Khun Khin Min Naing, a 24-year-old protest leader told news agency AFP about the protests on China. As per media reports, Chinese companies are extracting lead, a toxic metal which is used in lead-acid batteries, in huge quantities in Myanmar, which as per WHO can pollute local soil and water supplies. As a result of the heavy machinery development by China, the tribes of Myanmar are rising in dissent. US bans entry of Myanmar, Afghanistan and other nation residents In another significant development, US President Donald Trump signed a proclamation to ban entry of individuals from 12 nations – Afghanistan, Myanmar, Chad, the Republic of the Congo, Equatorial Guinea, Eritrea, Haiti, Iran, Libya, Somalia, Sudan, and Yemen, citing national security and public safety threats, according to the White House, as per a report by news agency ANI. Trump has partially restricted and limited the entry of nationals from the seven nations: Burundi, Cuba, Laos, Sierra Leone, Togo, Turkmenistan, and Venezuela. According to the White House, these restrictions distinguish between, but apply to both, the entry of immigrants and nonimmigrants. (With inputs from agencies)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store